Compare · CSII vs MDLN
CSII vs MDLN
Side-by-side comparison of Cardiovascular Systems Inc. (CSII) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CSII and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $50.91B, about 72.9x CSII ($698.7M).
- MDLN has hit the wire 5 times in the past 4 weeks while CSII has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 8 for CSII).
- Company
- Cardiovascular Systems Inc.
- Medline Inc.
- Price
- $19.99+0.05%
- $38.78+3.02%
- Market cap
- $698.7M
- $50.91B
- 1M return
- -
- +7.57%
- 1Y return
- -
- -4.83%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1981
- 2025
- News (4w)
- 0
- 5
- Recent ratings
- 8
- 25
Cardiovascular Systems Inc.
Cardiovascular Systems, Inc., a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company has a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
Latest CSII
- SEC Form SC 13G/A filed by Cardiovascular Systems Inc. (Amendment)
- SEC Form 15-12G filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
- SEC Form S-8 POS filed by Cardiovascular Systems Inc.
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)